Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Tissue Engineering. Part A
|
March 13, 2008
Feasibility study of a novel urinary bladder bioreactor
M Chad Wallis, Herman Yeger, Lisa Cartwright, et al.
Cancer Research
|
August 17, 2005
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma
Bikul Das, Herman Yeger, Rika Tsuchida, et al.
Frontiers in Medicine
|
April 1, 2022
Decline in Respiratory Functions in Hospitalized SARS-CoV-2 Infected Cancer Patients Following Cytotoxic Chemotherapy-An Additional Risk for Post-chemotherapy Complications
Maha Ahmed Al-Mozaini, Mihyar Islam, Abu Shadat M Noman, et al.
Cancers
|
July 2, 2021
3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model
Reza Bayat Mokhtari, Bessi Qorri, Manpreet Sambi, et al.
BMC Cancer
|
February 26, 2017
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Reza Bayat Mokhtari, Narges Baluch, Micky Ka Hon Tsui, et al.
The Laryngoscope
|
November 22, 2016
Bioengineering pediatric scaffold-free auricular cartilaginous constructs
Pedram Akbari, Stephen D Waldman, Sharon L Cushing, et al.
BMC Cancer
|
September 1, 2019
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane
Reza Bayat Mokhtari, Narges Baluch, Evgeniya Morgatskaya, et al.
American Journal of Cancer Research
|
November 18, 2024
Cell-based assay to detect small molecules restoring levels of let-7 miRNAs
Sirinapa Szewczyk, Brian Buckley, Mikhail Chernov, et al.
The American Journal of Pathology
|
April 11, 2009
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Journal of Cell Communication and Signaling
|
March 3, 2010
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Tissue Engineering. Part A
|
March 13, 2008
Feasibility study of a novel urinary bladder bioreactor
M Chad Wallis, Herman Yeger, Lisa Cartwright, et al.
Cancer Research
|
August 17, 2005
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma
Bikul Das, Herman Yeger, Rika Tsuchida, et al.
Frontiers in Medicine
|
April 1, 2022
Decline in Respiratory Functions in Hospitalized SARS-CoV-2 Infected Cancer Patients Following Cytotoxic Chemotherapy-An Additional Risk for Post-chemotherapy Complications
Maha Ahmed Al-Mozaini, Mihyar Islam, Abu Shadat M Noman, et al.
Cancers
|
July 2, 2021
3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model
Reza Bayat Mokhtari, Bessi Qorri, Manpreet Sambi, et al.
BMC Cancer
|
February 26, 2017
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Reza Bayat Mokhtari, Narges Baluch, Micky Ka Hon Tsui, et al.
The Laryngoscope
|
November 22, 2016
Bioengineering pediatric scaffold-free auricular cartilaginous constructs
Pedram Akbari, Stephen D Waldman, Sharon L Cushing, et al.
BMC Cancer
|
September 1, 2019
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane
Reza Bayat Mokhtari, Narges Baluch, Evgeniya Morgatskaya, et al.
American Journal of Cancer Research
|
November 18, 2024
Cell-based assay to detect small molecules restoring levels of let-7 miRNAs
Sirinapa Szewczyk, Brian Buckley, Mikhail Chernov, et al.
The American Journal of Pathology
|
April 11, 2009
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Journal of Cell Communication and Signaling
|
March 3, 2010
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Page
of 10